Banson Pharmaceuticals Private Limited, a active private limited company, was established on 05 May 1995 in Punjab, Punjab, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232PB1995PTC016354. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹2.00 Cr.
It upholds a compliant status. Employing 9 professional, Its leadership includes Anish Kumar Bansal (Director), Santosh Kumar Bansal (Director). Past directors included Kiran Bansal, Sham Lal, Rajesh Kumar Bansal. It holds ₹16.71 Cr open charges and ₹7.70 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at # Dewana Streetnabha Distt Patiala, Punjab, Punjab, 147201.
U24232PB1995PTC016354
016354
05 May 1995
₹2.00 Cr
₹2.00 Cr
Roc Chandigarh
Unlisted
Active
Explore comprehensive insights into Banson Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anish Kumar Bansal | Director | 02 Apr 2022 | Current |
| Santosh Kumar Bansal | Director | 05 May 1995 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 02 Apr 2022 | Past |
| Pramod Abcsdd | Director | 06 Jun 2009 | Past |
| Pramod Abcsdd | Director | 06 Jun 2009 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Banson Pharmaceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 4.54% decrease. The company also saw a substantial fall in profitability, with a 19.62% decrease in profit. The company's net worth Soared by an impressive increase of 12.94%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Banson Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹167,128,672.00
₹77,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Sep 2025 | Canara Bank | ₹1.01 Cr | Open |
| 18 Sep 2025 | Canara Bank | ₹6.75 Cr | Open |
| 18 Sep 2025 | Canara Bank | ₹1.94 M | Open |
| 18 Sep 2025 | Canara Bank | ₹0.90 M | Open |
| 18 Sep 2025 | Canara Bank | ₹1.00 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Banson Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Banson Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Banson Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Canara Bank amounted to Rs. 1.01 Cr with Charge ID 101167617 was registered on 18 Sep 2025. was recorded as a recent event.
Progress on A charge with Canara Bank amounted to Rs. 6.75 Cr with Charge ID 101167356 was registered on 18 Sep 2025. was documented.
Progress on A charge with Canara Bank amounted to Rs. 0.19 Cr with Charge ID 101167348 was registered on 18 Sep 2025. was documented.
A charge with Canara Bank amounted to Rs. 0.09 Cr with Charge ID 101167336 was registered on 18 Sep 2025. was recorded as a recent event.
Progress on A charge with Canara Bank amounted to Rs. 1.00 Cr with Charge ID 101167333 was registered on 18 Sep 2025. was documented.
A charge with Axis Bank Limited amounted to Rs. 1.00 Cr with Charge ID 101072297 was registered on 27 Mar 2025. was recorded as a recent event.
The CIN of Banson Pharmaceuticals Private Limited is U24232PB1995PTC016354.
Banson Pharmaceuticals Private Limited is headquartered at # Dewana Streetnabha Distt Patiala, Punjab, Punjab, 147201.
Banson Pharmaceuticals Private Limited was incorporated on 05 May 1995.
The current directors of Banson Pharmaceuticals Private Limited are
The primary industry of Banson Pharmaceuticals Private Limited is Manufacturing.
Banson Pharmaceuticals Private Limited is unlisted.
The authorized capital of Banson Pharmaceuticals Private Limited is ₹2.00 Cr, and the paid-up capital is ₹2.00 Cr.
The compliance status of Banson Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX